Market Overview:
The global H1N1 vaccines market is expected to grow at a CAGR of 9.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of H1N1 infections, rising demand for preventive measures against pandemics, and technological advancements in vaccine development. Based on type, the intramuscular vaccines segment is expected to account for the largest share of the global H1N1 vaccines market in 2018. This segment is also projected to grow at a CAGR of 9.8% from 2018 to 2030. Intramuscular vaccines are administered through injections and are considered as one of the most effective ways to prevent diseases caused by viruses or bacteria. They are also preferred over other types of vaccines due their long-term immunity potential and low risk for adverse effects associated with them. Based on application, influenza is estimated to account for the largest share of the global H1N1 vaccine market in 2018 followed by meningococcal disease.
Product Definition:
A vaccine is a biological preparation that improves immunity to a particular disease. H1N1 vaccines are used to improve immunity against the H1N1 virus.
Intramuscular Vaccines:
Intramuscular vaccines are vaccines that are injected into the muscle rather than the bloodstream. The main aim of this type of vaccine is to stimulate immunity in the body and provide protection against diseases. Intramuscular injections can be administered to any person irrespective of age, sex, or health conditions without having an adverse effect on them.
Intranasal Vaccines:
Intranasal vaccines are vaccines that are administered by spraying into the nasal passage. The nose is a very effective way of delivering a vaccine as it protects against infections before the immune system can respond. Intranasal vaccines have been used for decades and have been found to be more effective than other methods such as injectable or oral vaccination.
The first intranasal H1N1 vaccine was licensed in 2009.
Application Insights:
Based on the application, the global influenza vaccines market is segmented into seasonal influenza, H1N1 and other viral infections (eg. rhinovirus, coronavirus), meningococcal disease, cervical cancer and others. The seasonal influenza segment dominated the overall market in 2017 owing to its high usage rate during the annual flu season which occurs in November-December of a year. This is due to its wide spectrum of target population including both healthy as well as immunocompromised individuals which makes it highly effective among all types of viruses.
The use of this vaccine during any type of meningococcal disease outbreaks such as epidemics or pandemics will be highly beneficial since these are caused by different strains related to A(H1N1) virus that will help control these diseases at their initial stages before they spread further resulting in reduced mortality rates among infected patients along with improved immunity against future occurrences for a longer period of time.
Regional Analysis:
North America dominated the global market in 2017, owing to a rise in demand for vaccination against various infectious diseases. The region is expected to maintain its dominance over the forecast period due to factors such as high disposable income and rising awareness about immunization programs. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing investments by vaccine manufacturers and growing focus on controlling highly contagious diseases like H1N1 influenza virus.
Moreover, emerging economies like India are making efforts towards manufacturing affordable vaccines that can be used across different age groups and genders thus boosting regional growth prospects considerably. Moreover, China’s recent outbreak of COVID-19 has led global governments around the world including U.S., UK, Germany & France among others have shown interest in collaborating with China for producing these vaccines thus positively influencing regional growth trends significantly over next few years.
Growth Factors:
- Increasing awareness about the benefits of vaccination against H1N1 virus among people.
- Government initiatives and campaigns for vaccination against H1N1 virus.
- Availability of vaccines at affordable prices across the globe
Scope Of The Report
Report Attributes
Report Details
Report Title
H1N1 Vaccines Market Research Report
By Type
Intramuscular Vaccines, Intranasal Vaccines, Intradermal Vaccines
By Application
Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella, Others
By Companies
Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla, Merck, Sinovac Biotech, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global H1N1 Vaccines Market Report Segments:
The global H1N1 Vaccines market is segmented on the basis of:
Types
Intramuscular Vaccines, Intranasal Vaccines, Intradermal Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Baxter International
- Sanofi
- GSK
- Pfizer
- Mitsubishi Tanabe Pharma
- Hualan Biological Engineering
- Cipla
- Merck
- Sinovac Biotech
- Abbott
Highlights of The H1N1 Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intramuscular Vaccines
- Intranasal Vaccines
- Intradermal Vaccines
- By Application:
- Influenza
- Meningococcal
- Cervical Cancer
- Pneumococcal
- Hepatitis
- Measles
- Mumps
- Rubella
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the H1N1 Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
H1N1 vaccines are a type of vaccine that helps protect people from the H1N1 virus. They help the body build immunity to the virus, and can help prevent infection if you get vaccinated.
Some of the key players operating in the h1n1 vaccines market are Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla, Merck, Sinovac Biotech, Abbott.
The h1n1 vaccines market is expected to register a CAGR of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 H1N1 Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 H1N1 Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 H1N1 Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the H1N1 Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global H1N1 Vaccines Market Size & Forecast, 2018-2028
4.5.1 H1N1 Vaccines Market Size and Y-o-Y Growth
4.5.2 H1N1 Vaccines Market Absolute $ Opportunity
Chapter 5 Global H1N1 Vaccines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 H1N1 Vaccines Market Size Forecast by Type
5.2.1 Intramuscular Vaccines
5.2.2 Intranasal Vaccines
5.2.3 Intradermal Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global H1N1 Vaccines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 H1N1 Vaccines Market Size Forecast by Applications
6.2.1 Influenza
6.2.2 Meningococcal
6.2.3 Cervical Cancer
6.2.4 Pneumococcal
6.2.5 Hepatitis
6.2.6 Measles
6.2.7 Mumps
6.2.8 Rubella
6.2.9 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global H1N1 Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 H1N1 Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America H1N1 Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America H1N1 Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America H1N1 Vaccines Market Size Forecast by Type
9.6.1 Intramuscular Vaccines
9.6.2 Intranasal Vaccines
9.6.3 Intradermal Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America H1N1 Vaccines Market Size Forecast by Applications
9.10.1 Influenza
9.10.2 Meningococcal
9.10.3 Cervical Cancer
9.10.4 Pneumococcal
9.10.5 Hepatitis
9.10.6 Measles
9.10.7 Mumps
9.10.8 Rubella
9.10.9 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe H1N1 Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe H1N1 Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe H1N1 Vaccines Market Size Forecast by Type
10.6.1 Intramuscular Vaccines
10.6.2 Intranasal Vaccines
10.6.3 Intradermal Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe H1N1 Vaccines Market Size Forecast by Applications
10.10.1 Influenza
10.10.2 Meningococcal
10.10.3 Cervical Cancer
10.10.4 Pneumococcal
10.10.5 Hepatitis
10.10.6 Measles
10.10.7 Mumps
10.10.8 Rubella
10.10.9 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific H1N1 Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific H1N1 Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific H1N1 Vaccines Market Size Forecast by Type
11.6.1 Intramuscular Vaccines
11.6.2 Intranasal Vaccines
11.6.3 Intradermal Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific H1N1 Vaccines Market Size Forecast by Applications
11.10.1 Influenza
11.10.2 Meningococcal
11.10.3 Cervical Cancer
11.10.4 Pneumococcal
11.10.5 Hepatitis
11.10.6 Measles
11.10.7 Mumps
11.10.8 Rubella
11.10.9 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America H1N1 Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America H1N1 Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America H1N1 Vaccines Market Size Forecast by Type
12.6.1 Intramuscular Vaccines
12.6.2 Intranasal Vaccines
12.6.3 Intradermal Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America H1N1 Vaccines Market Size Forecast by Applications
12.10.1 Influenza
12.10.2 Meningococcal
12.10.3 Cervical Cancer
12.10.4 Pneumococcal
12.10.5 Hepatitis
12.10.6 Measles
12.10.7 Mumps
12.10.8 Rubella
12.10.9 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) H1N1 Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) H1N1 Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) H1N1 Vaccines Market Size Forecast by Type
13.6.1 Intramuscular Vaccines
13.6.2 Intranasal Vaccines
13.6.3 Intradermal Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) H1N1 Vaccines Market Size Forecast by Applications
13.10.1 Influenza
13.10.2 Meningococcal
13.10.3 Cervical Cancer
13.10.4 Pneumococcal
13.10.5 Hepatitis
13.10.6 Measles
13.10.7 Mumps
13.10.8 Rubella
13.10.9 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 H1N1 Vaccines Market: Competitive Dashboard
14.2 Global H1N1 Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Baxter International
14.3.3 Sanofi
14.3.4 GSK
14.3.5 Pfizer
14.3.6 Mitsubishi Tanabe Pharma
14.3.7 Hualan Biological Engineering
14.3.8 Cipla
14.3.9 Merck
14.3.10 Sinovac Biotech
14.3.11 Abbott
